Announced
Completed
Synopsis
Tempus Ex Machina, a sports technology startup, completed the acquisition of Biocore, a biomechanical engineering, with its data science teams developing analytics platforms that allow teams, federations and athletes to understand and prevent injuries. Financial terms were not disclosed. “We have been utilising Tempus Ex’s proprietary FusionFeed technology for quite some time and it has revolutionised our technology and processes,” Dr Jeff Crandall, Biocore Chief Executive.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.